Pantoprazol Braiter Pentafarma - Sociedade Tecnico-Medicinal (Pantoprazole)

Pantoprazole, the active ingredient in Pantoprazol Braiter Pentafarma - Sociedade Tecnico-Medicinal, is a proton pump inhibitor presented as a tablet for oral use. It reduces stomach acid production and is used to treat conditions such as gastro‑oesophageal reflux disease and peptic ulcer disease in adults.

GNH USA supplies Pantoprazol Braiter Pentafarma - Sociedade Tecnico-Medicinal as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Pantoprazole is a proton pump inhibitor that acts on the gastric acid secretion pathway, providing relief in several acid‑related disorders. - Gastro‑oesophageal reflux disease (GERD): helps heal erosive esophagitis and reduces heartburn episodes. - Peptic ulcer disease: promotes ulcer healing by maintaining a low‑acid gastric environment. - Zollinger‑Ellison syndrome: controls excessive gastric acid secretion associated with gastrin‑producing tumours.

Pantoprazole is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Headache: mild to moderate intensity. - Diarrhoea: usually self‑limiting. - Nausea: occasional and transient. - Abdominal pain: mild discomfort. - Flatulence: increased intestinal gas. - Constipation: occasional bowel habit change.

Serious or Rare Side Effects: - Clostridioides difficile infection: severe colitis risk. - Acute interstitial nephritis: renal inflammation. - Hypomagnesemia: low serum magnesium levels. - Stevens‑Johnson syndrome: severe skin reaction. - Hepatic dysfunction: elevated liver enzymes. - Fracture risk: long‑term bone density reduction.

When prescribing Pantoprazole, clinicians should consider several safety aspects. - Assess renal function: adjust use in severe impairment. - Monitor magnesium levels: especially with prolonged therapy. - Evaluate bone health: consider calcium/vitamin D supplementation for long‑term users. - Review concomitant medications: potential for altered absorption of drugs requiring acidic pH. - Pregnancy and lactation: use only if clearly needed after risk‑benefit assessment. - Store at ambient temperature: keep in the original container, protect from moisture and direct sunlight.

Pantoprazole may affect the pharmacokinetics of several co‑administered medicines.

Major Interactions (Avoid): - Ketoconazole or itraconazole: reduced antifungal absorption. - Atazanavir: markedly decreased antiviral exposure. - Clopidogrel: diminished antiplatelet effect.

Moderate Interactions (Monitor Closely): - Warfarin: possible increase in INR. - Digoxin: slight rise in serum levels. - Methotrexate (high dose): reduced renal clearance. - Iron supplements: decreased iron absorption when taken simultaneously.